Skip to main content
Journal ArticleOPEN ACCESS

Overall survival of patients with hepatocellular carcinoma receiving sorafenib versus selective internal radiation therapy with predicted osimetry in the SARAH trial

  • Hawkins N
  • Ross P
  • Palmer D
  • et al.
Annals of Oncology (2019) 30 v282
DOI: 10.1093/annonc/mdz247.063
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The NCI Common Terminology Criteria for Adverse Events v3.0 is a descriptive terminology which can be utilized for Adverse Event (AE) reporting. A grading (severity) scale is provided for each AE term.

Cite

CITATION STYLE

APA

Hawkins, N. S., Ross, P. J., Palmer, D. H., Chatellier, G., Pereira, H., & Vilgrain, V. (2019). Overall survival of patients with hepatocellular carcinoma receiving sorafenib versus selective internal radiation therapy with predicted osimetry in the SARAH trial. Annals of Oncology, 30, v282. https://doi.org/10.1093/annonc/mdz247.063

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free